People
Episurf Medical appoints Dr Kevin D. Plancher as lead investigator for the Episealer IDE study
7 October 2019 -

Episurf Medical AB (STO: EPIS B), a provider of minimally invasive and individualised treatment alternatives for people with painful joint injuries, announced on Friday that Dr Kevin D. Plancher, MD, MPH, of Plancher Orthopaedics & Sport Medicine, New York, has been appointed lead investigator for the company's IDE clinical study, EPIC-Knee: Episealer Knee System IDE Clinical Study.

In his new role as lead investigator, Dr Plancher will serve as a medical advisor to Episurf Medical and the other sites and investigators for any trial-related questions. Dr Plancher will also be one of the surgeons performing surgeries in the clinical trial.

Dr Plancher is a board-certified orthopaedic surgeon and sports medicine expert with extensive experience in treating knee cartilage injuries and an expert in minimally invasive procedures.

Currently, he is a clinical professor in Orthopaedics at Albert Einstein College of Medicine in New York. He is an active member of many prestigious national and international societies and serves on the board of the American Academy of Orthopaedic Surgeons.

Login
Username:

Password: